Registration Trial News Today

SALT LAKE CITY, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, part of the Intermountain

--Registration Trial for uUTI Ongoing and On Track-- --Cash Runway until Mid-2024-- DUBLIN, Ireland and CHICAGO, May 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage

Worldwide infection is like 0.2%, an order of magnitude lower into the us a bit higher. but nowhere near 2%. it is an enormous mistake and really unfortunate that we have a person who didnt have the expertise to lead the response. laura: doctor faucis credibility, he is pushing pushing pushing this idea of vaccines on younger kids and hoping they will be ready by the end of this year. >> if you are a parent of a 12-year-old or 12 or younger how hopeful should you be that they will get a vaccine ...

ERC-USA ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma IRVINE, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- ERC-USA and the University of California, Irvine (UCI), toda...